AlTorress

CYH, MACD Histogram just turned positive

Long
NYSE:CYH   Community Health Systems, Inc.
This is a Bullish indicator signaling CYH's price could rise from here. Traders may explore going long the stock or buying call options. Tickeron A.I. dvisor identified 41 similar cases where CYH's MACD histogram became positive, and 36 of them led to successful outcomes. Odds of Success: 88%. Current price $4.76 crossed the support line at $4.66 and is trading between $4.83 resistance and $4.66 support lines. Throughout the month of 09/01/20 - 10/02/20, the price experienced a -14% Downtrend, while the week of 09/25/20 - 10/02/20 shows a +9% Uptrend.

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where CYH's RSI Indicator exited the oversold zone, 23 of 30 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 77%.

The Stochastic Indicator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. Tickeron A.I. detected that in 50 of 61 cases where CYH's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 82%.

The 50-day Moving Average for CYH moved above the 200-day moving average on August 07, 2020. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Following a +5.21% 3-day Advance, the price is estimated to grow further. Considering data from situations where CYH advanced for three days, Tickeron A.I. shows that in 249 of 325 cases, the price rose further within the following month. The odds of a continued upward trend are 77%.

CYH may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.